Vystar Corporate Update Highlights

Posted on: Sep 1, 2017

New Vytex Latex Product Lines & Applications, R&D, Marketing

ATLANTA, Aug. 30, 2017 (GLOBE NEWSWIRE) — Vystar Corp. (OTC Market:VYST) is providing an update on the Company’s R&D and expanding product lines and applications for Vytex® deproteinized natural rubber latex, which position it for rapid growth in the coming year and beyond.

Read More

Read More...

Vytex Introduces Dry Natural Rubbers At International Latex Conference

Posted on: Aug 17, 2017

Vystar Director Matthan Attracts Global Interest in Advances in Ultra Low Protein Vytex, Non Rubber Latices, and Dry Natural Rubbers At International Latex Conference

ATLANTA and AKRON, Ohio, Aug. 15, 2017 (GLOBE NEWSWIRE) — Vystar Corp. (OTC Market:VYST) Board of Directors Member and Research & Development Director Ranjit K. Matthan, Ph.D., was a speaker at the International Latex Conference session on August 9th where he shared recent advances in formulations of Vytex® Ultra-Low Protein and Non-Rubber Latices (ULP-NRSL) that will allow for affordable, broader range end use applications with reduced risk of causing or triggering latex allergies.

Read More

Read More...

Vystar Receives Indonesia Patent

Posted on: Jun 7, 2017

Vystar Receives Indonesia Patent Notice of Allowance for Deproteinization of Vytex Natural Rubber Latex

Atlanta, GA – June 7, 2017 – Vystar Corp. (OTC Market: VYST) has received a notice of allowance from Indonesia for a patent regarding “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same.” Vystar now holds 11 international and four domestic patents related to its latex deproteinization process which results in Vytex®, a natural rubber latex (NRL) virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions from direct contact.

“This notice of allowance provides important intellectual property (IP) protection for Vystar as we actively work with latex producers and manufacturers in Indonesia and seek to develop relationships with additional ones, particularly medical glove manufacturers to meet the growing demand for low protein, non-powdered, medical gloves,” stated William Doyle, CEO of Vystar.

Vystar now has IP protection in Indonesia, Malaysia and India, which are three of the world’s top five producers of natural rubber, with Malaysia ranking first in latex glove production. The latex industry is estimated at approximately US$1.3 billion.

Latex allergies and powdered gloves have become a major concern in the healthcare industry, with some facilities banning latex gloves and the US recently banning powdered gloves. However, surgeons and medical professionals prefer latex over synthetic latex, vinyl and other materials due to its superior tactile sensitivity, puncture resistance, strength, durability and flexibility. This presents a tremendous market opportunity for Vytex medical gloves as they are virtually free of allergy-causing proteins while providing all the benefits of latex that healthcare workers want, and they don’t need powder to ease glove donning and removal.

Additionally, Vytex is sustainably sourced and completely biodegradable, in sharp contrast to petrochemical based synthetic latex or petrochemical based disposable gloves. Plus, those who need to wear disposable gloves appreciate that Vytex is virtually odor-free, without the strong odor of traditional latex. The Vytex deproteinization process also removes the source of the latex odor, making Vytex more eco friendly than its competitors as there is no need for the excessive water rinses to remove odor during the manufacturing process or the need for artificial fragrance to mask the odor.

Competitively priced against traditional latex, Vytex is a superior material for more than 40,000 applications that typically use latex or petrochemical based materials. Vytex can be used in medical gloves, catheters and devices; condoms; mattresses, toppers and pillows; cushions; balloons; adhesives; sports equipment, footwear; padding, apparel and threads.

For details on Vytex licensing, deproteinization or purchase, contact info@vytex.com or (866) 674-5238, x1 or visit Vytex.com or facebook:.

Read More...

Major Latex Foam Producer Lien ‘A Partners with Vystar, CEO Invests in Vystar

Posted on: Jun 1, 2017

Lien ‘A, Vystar to Exhibit at Home Furnishings Manufacturing Solutions Expo, June 7-8

Atlanta, GA– June 1, 2017 – Vystar Corp. (OTC: VYST), has formed a strategic partnership with Lien ‘A, pairing Vystar’s multi-patented, all-natural, virtually allergen free Vytex® latex with one of the top eco-friendly latex foam producers in Vietnam who provides natural rubber latex (NRL) products to 31 countries worldwide. Over the past year, Lien ‘A’s CEO Lam Ngoc Minh took significant equity positions in Vystar and NHS Holdings, LLC (NHS), Vystar’s exclusive distributor for Vytex foam, to assist in expanding Vystar’s supply chain and drive adoption of a better, cleaner material that can be used in 40,000 products.

Vystar and Lien ‘A will be exhibiting together at the Home Furnishings Manufacturing Solutions Expo, in the Georgia World Congress Center, June 7-8 in Atlanta, where they will introduce Vytex to furniture manufacturers who have been seeking sustainably sourced materials and more resilient, eco friendly alternatives to petrochemical-based foams and traditional latex.

“Minh joins a core group of Vystar investors who have invested $20 million in Vystar since inception to launch Vytex in multiple vertical markets and spur the latex and plastics industries to change to sustainably sourced, more durable and biodegradable materials,” stated William Doyle, Vystar CEO. “We have investors from the medical industry seeking to resolve allergy issues with latex gloves, gowns and other medical products that can have life saving impact for those with latex allergies. And our newest investor is looking to do the same in bedding.”

“There is a decade long strong and growing global demand for high quality, natural, eco-friendly products and Vytex is a versatile product that can fill that need,” stated Steven Rotman, CEO of NHS. “Vytex’s all-natural, ultra low protein and ultra low nitrosamine formulations that help lessen the risk of latex-induced allergic reactions and create a safer manufacturing environment are unique in the latex industry. They give Vytex the potential to capture a large portion of the foam mattress, pillow and home furnishing cushions market in the U.S. and abroad. Lien ‘A’s advanced foam manufacturing processes produce a superior, high-quality Vytex foam that helps fill that demand. Vytex is the future of foam.”

Vytex and NHS are working with Lien ‘A to build and manage relationships with mattress and pillow manufacturers who will utilize Lien ‘A-produced Vytex foam cores for bedding products that will be sold by retailers throughout the Americas. Lien ‘A and NHS have Vytex foam cores available in East and West Coast warehouses to enable fast and efficient delivery to manufacturers nationwide.

“We share with Lien ‘A the same devotion to quality and the environment,” noted William Doyle, CEO of Vystar Corp. “Vytex foam is only as good as the manufacturers who create it from our raw latex, and Lien ‘A has passed our stringent quality tests with flying colors for ability to consistently meet exacting specifications for a broad array of foams. Vytex offers the eco-friendly benefits as well as being more durable, resilient, and odor free at roughly the same cost of NRL in manufacturing ease, durability, and aging, while being better and cleaner for the environment. Partnering with Lien ‘A will ultimately help us deliver the advantages of Vytex to more consumers.”

Vytex is the only all natural latex product with virtually all the antigenic proteins that cause latex allergies removed. It offers an odor free, brighter, whiter, more buoyant and stronger latex without all the chemicals and dyes in competitors’ latex products or the toxic petrochemical off-gassing, lack of durability and bacterial issues common to memory foam products.

# # #

About Lien ‘A
Lien ‘A is a private company, founded by Mr. Lam Ngoc Hiep in 1966, with the motto  “freshen your living with outstanding products.” Lien ‘A is an innovator in creating green, environmentally friendly products and has grown into one of the largest producers of natural latex mattresses in Vietnam, in addition to producing bed linens, furniture and pillows. In 2010, Lien ‘A was awarded the prestigious ECO Certificate from the ECO-INSTITUT of Cologne, Germany, and the “LGA tested quality” certificate from TUV Rheinland Products GmbH for exceeding quality standards. Lien ‘A’s three factories export to 31 countries via its worldwide warehouse distribution network. For more information contact: maydelotte@liena.vn

About Nature’s Home Solutions (NHS Holdings)
NHS, a Worcester, MA-based distribution company devoted to identifying and bringing to market innovative, high quality, certified sustainable, eco-friendly durable materials and components for use in the home furnishings, apparel, and other markets. Contact: Steven Rotman.

About Vystar Corporation

Based in Atlanta, GA, Vystar® Corporation (OTC Pink: VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, balloons, condoms, medical devices, mattresses, toppers, and pillows. For more information, visit www.vytex.com.

Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are “Forward- Looking Statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as “believes,” “anticipates,” “intends,” “plans,” “expects,” and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.

Read More...

Vytex Featured on New To The Street

Posted on: Apr 30, 2017

Anchor Ken Evseroff welcomes Vystar Corporation’s (OTC PINK: VYST) CEO Bill Doyle back to introduce new viewers to Vystar’s ongoing efforts to provide a superior latex that can improve thousands of products, including mattresses and pillows for a better night’s rest.

“We appreciate the opportunity to discuss in more detail how Vystar’s Vytex solves some problems for the latex and plastic materials industries,” states Bill Doyle, CEO of Vystar. He further states,”Vytex is a sustainable, natural, latex material from which we remove all protein virtually, resulting in an odor free, stronger and more resilient material that doesn’t have any petrochemical off-gassing and also reduces the risk of experiencing or developing latex allergies. We are working with multiple industries to replace latex, memory foam and plastics with Vytex in products such as electrical gloves, medical gloves, balloons, foam for mattresses, pillows, cushions and padding; elastic threads for undergarments and sportswear; and industrial adhesives. It’s a multi-billion dollar raw materials opportunity.”

Read More...

Vystar Receives 3 Patent Notices of Allowance

Posted on: Apr 11, 2017

Vystar Receives 3 Patent Notices of Allowance for Vytex Latex Deproteinization

Atlanta, GA – April 20, 2017 – Vystar Corp. (OTC Market: VYST) has received notice of allowance for three international patents regarding “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same” from:
1. Malaysia – (2010003317)
2. Guatemala (2010-000208) and
3. India -(2487/KOLNP/2010)

The addition of these three international patents brings the total to 14 global patents, with 10 being international and four domestic. This further expands Vystar’s patent portfolio related to its latex deproteinization process used in Vytex® natural rubber latex (NRL) which removes virtually all allergy-causing proteins from NRL, thus reducing risk of developing or experiencing allergic reactions from direct contact with latex.

“These international notices of allowance provide intellectual property (IP) protection in two of the top six latex-producing countries in the world — primary locations where we do business and are actively seeking additional manufacturing and/or processing partners for our ultra low protein Vytex raw material,” stated William Doyle, CEO of Vystar. “The claims the international patent offices are allowing will serve to further strengthen our IP around Vystar’s breakthrough deproteinization process and protect our shareholders’ investments. Also, of the top eight consumers of latex globally, Vystar now has patents in six of those countries/unions, plus applications pending in several more.”

Vystar has multiple layers of IP protection for Vytex® ultra low protein latex that extend beyond patents. Vystar controls the manufacture of the proprietary deproteinization kit that is sold to licensed Vytex producers. Producers add the kit to field latex and use standard latex manufacturing equipment with slight modifications. Vystar tests every batch of Vytex to certify that it meets the high standards of Vytex brand latex.

Removing the proteins and other non-rubbers results in the purest, cleanest, and odor-free latex that is more resilient and stronger than competitors’ lattices, offers greater tactile sensitivity and puncture/tear resistance, creates a brighter, whiter foam and offers improved clarity and color for colored latex products such as balloons.

Competitively priced against traditional latex, Vytex is a superior material for more than 40,000 applications that typically use latex or petrochemical based materials. Vytex can be used in medical gloves, catheters and devices; condoms; mattresses, toppers and pillows; cushions; balloons; adhesives; sports equipment, footwear; padding, apparel and threads.

For details on Vytex licensing, deproteinization or purchase, contact us or (866) 674-5238, x1.

Read More...

Institutional Analyst Inc. Initiates Coverage on Vytex

Posted on: Mar 22, 2017

Institutional Analyst Inc. Initiates Coverage on Vystar’s Vytex Better Cleaner Latex

Atlanta – March 22, 2017 – Institutional Analyst Inc. has initiated coverage of Vystar Corp., (OTC PINK: VYST), with a report in “Biotech Stock Review” detailing the market opportunity for Vystar as the exclusive creator and licensor of breakthrough patented processes that remove virtually all proteins and non-rubbers that cause latex allergies and odor from latex to create Vytex ® natural rubber latex (NRL) that can be used in over 40,000 products. The report is available on vytex.com/blog/ and InternetStockReview.com

“The coverage initiated by the Biotech Stock Review comes at an excellent time for potential investors as we now have a network of highly capable suppliers on a global basis to produce Vytex natural rubber latex,” stated CEO William Doyle. “It has been a long journey to perfect our breakthrough patented processes that remove virtually all proteins and non-rubbers that cause latex allergies from latex to create Vytex®, which is a technically superior, sustainable, biodegradable, more durable and more ecofriendly product than traditional latex and petrochemical-based materials. We are fortunate to have enlisted Institutional Analyst Inc. to provide ongoing coverage via “Biotech Stock Review” as we roll Vytex out to our three initial target markets: foam for the home furnishings market, adhesives for the apparel market and latex gloves for the medical market.”

Roland Rick Perry, Editor of Biotech Stock Review, stated, “Now that the process has been perfected, Vystar has a viable ‘Intel Inside’ business model whereby established producers of natural latex can create and sell cleaner, better latex which, most importantly, can be done with their existing processing equipment with minor modifications and processing costs associated with the Vytex deproteinization kit and licensing. With approximately 1.2 million metric tons of natural rubber latex purchased every year, Vystar is in the enviable position of garnering a small fee on each pound produced without the need to build plants and factories and the capital required to build them. They can instead work with established producers who can now offer their end purchasers a better latex and simultaneously expand natural latex into markets which, until now, were hampered due to allergy concerns – the best example being medical gloves.”

In a November 2016 report by Allied Market Research titled, “Global Disposable Gloves Market” based on key trends tracked, it is anticipated that the market is likely to be valued at $17.2 billion by 2022, registering a CAGR of 12.6% from 2016 to 2022. The report states “The natural rubber gloves segment accounted for around three-fifths revenue share, in 2015 and is expected to maintain its dominance during the forecast period.”

Vytex natural latex gloves allow surgeons and healthcare professionals to enjoy the superior tactile sensitivity and strength of latex gloves virtually without risk of developing or experiencing allergic reactions.  Vystar management believes that by reducing the risk of latex allergies, Vytex gloves may displace the weaker, less tactilely sensitive and less durable polyethylene, vinyl and nitrile gloves that many institutions transitioned to as a result of latex allergy concerns.

Vytex was recently featured on ION TV’s “New to the Street.” Click here to watch it.

For details on Vytex licensing, deproteinization or purchase, contact us or (866) 674-5238, x1

Read More...

Vytex, the Cleaner-Better Latex

Posted on: Mar 22, 2017

Institutional Analyst Inc. has initiated coverage of Vystar Corp., (VYST), with a report in “Biotech Stock Review” detailing the market opportunity for Vystar as the exclusive creator and licensor of breakthrough patented processes that remove virtually all proteins and non-rubbers that cause latex allergies and odor from latex to create Vytex ® natural rubber latex (NRL) that can be used in over 40,000 products.

Download the full Report in PDF Format (9MB).

Read More...

Vytex Featured on New To The Street, Aired on ION

Posted on: Mar 22, 2017

“New to the Street” host Ken Evseroff interviews Vystar CEO Bill Doyle, NHS and Rotmans Furniture CEO Steve Rotman and Hedge Fund Manager and Medical Doctor Joseph Allegra. They explore how Vytex is replacing materials that are non-biodegradable, have harmful off gassing, cause allergies or have noxious smells in 40,000 different products with a superior, yet budget-friendly alternative to traditional latex, memory foam, and other petrochemical-based materials. The segment aired on ION TV in New York on 3/20.

Read More...

Vystar Focuses on Vytex Latex Commodities and Licensing; Exits Sleep Diagnostics

Posted on: Jun 6, 2016

DURHAM, NC and ATLANTA, GA–(Marketwired – Jun 6, 2016) – Vystar Corp. (OTC PINK: VYST) has closed its Kiron Sleep Lab LLC division in Durham, NC in order to focus on its core business of Vytex® environmentally friendly, ultra low protein natural rubber latex commodities and licensing business.

Read More

Read More...